First Author: R.Altan-Yayc?oglu TURKEY
Co Author(s): M. Coban Karatas S. Sizmaz H. Canan
Purpose:
To report our experience and to evaluate the efficacy and safety of Ex-press Mini-Glaucoma Shunt. implantation
Setting:
All the patients were accepted and operated in Baskent University Adana Clinic and Research Center.
Methods:
Ex-press Mini-Glaucoma Shunt (P-200; Alcon Lab) was implanted to five eyes of four patients with end-stage glaucoma suffering from high intraocular pressure (IOP) and severe pain with full treatment. Three patients suffered from primary open-angle glaucoma and one from neovascular glaucoma. Success was defined as an IOP between 5 and 21 mmHg without further medication. IOP was measured on the 1 day, 1 week and 1 month following surgery.
Results:
Ex-press Mini-Glaucoma Shunt (P-200; Alcon Lab) was implanted to five eyes of four patients with end-stage glaucoma suffering from high intraocular pressure (IOP) and severe pain with full treatment. Three patients suffered from primary open-angle glaucoma and one from neovascular glaucoma. Success was defined as an IOP between 5 and 21 mmHg without further medication. IOP was measured on the 1 day, 1 week and 1 month following surgery.
Conclusions:
In the end stage glaucoma patients the Ex-press Mini Glaucoma Shunt is relatively safe and effective surgical procedure and provides satisfactory IOP control and medication reduction. FINANCIAL DISCLOSURE?: No
Please wait while information is loading.
